Transgelin 2 guards T cell lipid metabolism and antitumour function.
Journal
Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462
Informations de publication
Date de publication:
23 Oct 2024
23 Oct 2024
Historique:
received:
29
11
2023
accepted:
18
09
2024
medline:
24
10
2024
pubmed:
24
10
2024
entrez:
24
10
2024
Statut:
aheadofprint
Résumé
Mounting effective immunity against pathogens and tumours relies on the successful metabolic programming of T cells by extracellular fatty acids
Identifiants
pubmed: 39443795
doi: 10.1038/s41586-024-08071-y
pii: 10.1038/s41586-024-08071-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Nature Limited.
Références
Lim, S. A., Su, W., Chapman, N. M. & Chi, H. Lipid metabolism in T cell signaling and function. Nat. Chem. Biol. 18, 470–481 (2022).
pubmed: 35484263
pmcid: 11103273
doi: 10.1038/s41589-022-01017-3
Zhang, Y. et al. Enhancing CD8
pubmed: 28898698
pmcid: 5751418
doi: 10.1016/j.ccell.2017.08.004
Nava Lauson, C. B. et al. Linoleic acid potentiates CD8
pubmed: 36898381
doi: 10.1016/j.cmet.2023.02.013
Pan, Y. et al. Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism. Nature 543, 252–256 (2017).
pubmed: 28219080
pmcid: 5509051
doi: 10.1038/nature21379
Lin, R. et al. Fatty acid oxidation controls CD8
pubmed: 32075801
doi: 10.1158/2326-6066.CIR-19-0702
Reinfeld, B. I. et al. Cell-programmed nutrient partitioning in the tumour microenvironment. Nature 593, 282–288 (2021).
pubmed: 33828302
pmcid: 8122068
doi: 10.1038/s41586-021-03442-1
Long, L. et al. CRISPR screens unveil signal hubs for nutrient licensing of T cell immunity. Nature 600, 308–313 (2021).
pubmed: 34795452
pmcid: 8887674
doi: 10.1038/s41586-021-04109-7
Fox, C. J., Hammerman, P. S. & Thompson, C. B. Fuel feeds function: energy metabolism and the T-cell response. Nat. Rev. Immunol. 5, 844–852 (2005).
pubmed: 16239903
doi: 10.1038/nri1710
Byersdorfer, C. A. et al. Effector T cells require fatty acid metabolism during murine graft-versus-host disease. Blood 122, 3230–3237 (2013).
pubmed: 24046012
pmcid: 3814737
doi: 10.1182/blood-2013-04-495515
Pearce, E. L. et al. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 460, 103–107 (2009).
pubmed: 19494812
pmcid: 2803086
doi: 10.1038/nature08097
Jin, R. et al. Role of FABP5 in T cell lipid metabolism and function in the tumor microenvironment. Cancers 15, 657 (2023).
pubmed: 36765614
pmcid: 9913835
doi: 10.3390/cancers15030657
Liu, F. et al. Identification of FABP5 as an immunometabolic marker in human hepatocellular carcinoma. J. Immunother. Cancer 8, e000501 (2020).
pubmed: 32611686
pmcid: 7332195
doi: 10.1136/jitc-2019-000501
Matulonis, U. A. et al. Ovarian cancer. Nat. Rev. Dis. Primers 2, 16061 (2016).
pubmed: 27558151
pmcid: 7290868
doi: 10.1038/nrdp.2016.61
Matulonis, U. A. et al. Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study. Ann. Oncol. 30, 1080–1087 (2019).
pubmed: 31046082
doi: 10.1093/annonc/mdz135
Kandalaft, L. E., Dangaj Laniti, D. & Coukos, G. Immunobiology of high-grade serous ovarian cancer: lessons for clinical translation. Nat. Rev. Cancer 22, 640–656 (2022).
pubmed: 36109621
doi: 10.1038/s41568-022-00503-z
Song, M. et al. IRE1α–XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity. Nature 562, 423–428 (2018).
pubmed: 30305738
pmcid: 6237282
doi: 10.1038/s41586-018-0597-x
Cao, Y. et al. ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression. Nat. Commun. 10, 1280 (2019).
pubmed: 30894532
pmcid: 6426975
doi: 10.1038/s41467-019-09263-1
Anadon, C. M. et al. Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells. Cancer Cell 40, 545–557.e13 (2022).
pubmed: 35427494
pmcid: 9096229
doi: 10.1016/j.ccell.2022.03.008
Bowtell, D. D. The genesis and evolution of high-grade serous ovarian cancer. Nat. Rev. Cancer 10, 803–808 (2010).
pubmed: 20944665
doi: 10.1038/nrc2946
Digre, A. & Lindskog, C. The Human Protein Atlas—spatial localization of the human proteome in health and disease. Protein Sci. 30, 218–233 (2021).
pubmed: 33146890
doi: 10.1002/pro.3987
Conejo-Garcia, J. R. et al. Tumor-infiltrating dendritic cell precursors recruited by a β-defensin contribute to vasculogenesis under the influence of Vegf-A. Nat. Med. 10, 950–958 (2004).
pubmed: 15334073
doi: 10.1038/nm1097
Chae, C. S. et al. Tumor-derived lysophosphatidic acid blunts protective type-I interferon responses in ovarian cancer. Cancer Discov. 12, 1904–1921 (2022).
pubmed: 35552618
pmcid: 9357054
doi: 10.1158/2159-8290.CD-21-1181
Cubillos-Ruiz, J. R. et al. Reprogramming tumor-associated dendritic cells in vivo using miRNA mimetics triggers protective immunity against ovarian cancer. Cancer Res. 72, 1683–1693 (2012).
pubmed: 22307839
pmcid: 3319850
doi: 10.1158/0008-5472.CAN-11-3160
Cubillos-Ruiz, J. R. et al. Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity. J. Clin. Invest. 119, 2231–2244 (2009).
pubmed: 19620771
pmcid: 2719935
Cubillos-Ruiz, J. R. et al. ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis. Cell 161, 1527–1538 (2015).
pubmed: 26073941
pmcid: 4580135
doi: 10.1016/j.cell.2015.05.025
Scarlett, U. K. et al. Ovarian cancer progression is controlled by phenotypic changes in dendritic cells. J. Exp. Med. 209, 495–506 (2012).
pubmed: 22351930
pmcid: 3302234
doi: 10.1084/jem.20111413
Szklarczyk, D. et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 49, D605–D612 (2021).
pubmed: 33237311
doi: 10.1093/nar/gkaa1074
Wan, C. H. et al. Panorama of ancient metazoan macromolecular complexes. Nature 525, 339–344 (2015).
pubmed: 26344197
pmcid: 5036527
doi: 10.1038/nature14877
Yin, L. M., Ulloa, L. & Yang, Y. Q. Transgelin-2: biochemical and clinical implications in cancer and asthma. Trends Biochem. Sci. 44, 885–896 (2019).
pubmed: 31256982
doi: 10.1016/j.tibs.2019.05.004
Jo, S., Kim, H. R., Mun, Y. & Jun, C. D. Transgelin-2 in immunity: Its implication in cell therapy. J. Leukoc. Biol. 104, 903–910 (2018).
pubmed: 29749649
doi: 10.1002/JLB.MR1117-470R
Ortega, F. J. et al. Cytoskeletal transgelin 2 contributes to gender-dependent adipose tissue expandability and immune function. FASEB J. 33, 9656–9671 (2019).
pubmed: 31145872
doi: 10.1096/fj.201900479R
Na, B. R. et al. TAGLN2 regulates T cell activation by stabilizing the actin cytoskeleton at the immunological synapse. J. Cell Biol. 209, 143–162 (2015).
pubmed: 25869671
pmcid: 4395477
doi: 10.1083/jcb.201407130
Armstrong, E. H., Goswami, D., Griffin, P. R., Noy, N. & Ortlund, E. A. Structural basis for ligand regulation of the fatty acid-binding protein 5, peroxisome proliferator-activated receptor β/δ (FABP5-PPARβ/δ) signaling pathway. J. Biol. Chem. 289, 14941–14954 (2014).
pubmed: 24692551
pmcid: 4031543
doi: 10.1074/jbc.M113.514646
Furuhashi, M. & Hotamisligil, G. S. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat. Rev. Drug Discovery 7, 489–503 (2008).
pubmed: 18511927
doi: 10.1038/nrd2589
Fung, H. Y., Teryek, M., Lemenze, A. D. & Bergsbaken, T. CD103 fate mapping reveals that intestinal CD103
pubmed: 36332012
pmcid: 9901738
doi: 10.1126/sciimmunol.abl9925
Giles, J. R. et al. Shared and distinct biological circuits in effector, memory and exhausted CD8
pubmed: 36271148
pmcid: 10408358
doi: 10.1038/s41590-022-01338-4
Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189–196 (2016).
pubmed: 27124452
pmcid: 4944528
doi: 10.1126/science.aad0501
Scott, A. C. et al. TOX is a critical regulator of tumour-specific T cell differentiation. Nature 571, 270–274 (2019).
pubmed: 31207604
pmcid: 7698992
doi: 10.1038/s41586-019-1324-y
Hetz, C., Zhang, K. & Kaufman, R. J. Mechanisms, regulation and functions of the unfolded protein response. Nat. Rev. Mol. Cell Biol. 21, 421–438 (2020).
pubmed: 32457508
pmcid: 8867924
doi: 10.1038/s41580-020-0250-z
Chen, X. & Cubillos-Ruiz, J. R. Endoplasmic reticulum stress signals in the tumour and its microenvironment. Nat. Rev. Cancer 21, 71–88 (2021).
pubmed: 33214692
doi: 10.1038/s41568-020-00312-2
Yoshida, H., Matsui, T., Yamamoto, A., Okada, T. & Mori, K. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107, 881–891 (2001).
pubmed: 11779464
doi: 10.1016/S0092-8674(01)00611-0
Logue, S. E. et al. Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy. Nat. Commun. 9, 3267 (2018).
pubmed: 30111846
pmcid: 6093931
doi: 10.1038/s41467-018-05763-8
Morita, S. et al. Targeting ABL-IRE1α signaling spares ER-stressed pancreatic β cells to reverse autoimmune diabetes. Cell Metab. 25, 1207 (2017).
pubmed: 28467938
doi: 10.1016/j.cmet.2017.04.026
Di Conza, G., Ho, P. C., Cubillos-Ruiz, J. R. & Huang, S. C. Control of immune cell function by the unfolded protein response. Nat. Rev. Immunol. 23, 546–562 (2023).
pubmed: 36755160
doi: 10.1038/s41577-023-00838-0
Kim, H. R. et al. An essential role for TAGLN2 in phagocytosis of lipopolysaccharide-activated macrophages. Sci. Rep. 7, 8731 (2017).
pubmed: 28821818
pmcid: 5562783
doi: 10.1038/s41598-017-09144-x
Iyer, S. et al. Genetically defined syngeneic mouse models of ovarian cancer as tools for the discovery of combination immunotherapy. Cancer Discov. 11, 384–407 (2021).
pubmed: 33158843
doi: 10.1158/2159-8290.CD-20-0818
Zhang, K. Y. et al. Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer. Sci. Adv. 8, eabm1831 (2022).
pubmed: 35196078
pmcid: 8865800
doi: 10.1126/sciadv.abm1831
Snaebjornsson, M. T., Janaki-Raman, S. & Schulze, A. Greasing the wheels of the cancer machine: the role of lipid metabolism in cancer. Cell Metab. 31, 62–76 (2020).
pubmed: 31813823
doi: 10.1016/j.cmet.2019.11.010
Shender, V. O. et al. Proteome–metabolome profiling of ovarian cancer ascites reveals novel components involved in intercellular communication. Mol. Cell. Proteomics 13, 3558–3571 (2014).
pubmed: 25271300
pmcid: 4256505
doi: 10.1074/mcp.M114.041194
Perales-Puchalt, A. et al. Follicle-stimulating hormone receptor is expressed by most ovarian cancer subtypes and is a safe and effective immunotherapeutic target. Clin. Cancer Res. 23, 441–453 (2017).
pubmed: 27435394
doi: 10.1158/1078-0432.CCR-16-0492
Paffenholz, S. V. et al. Senescence induction dictates response to chemo- and immunotherapy in preclinical models of ovarian cancer. Proc. Natl Acad. Sci. USA 119, e2117754119 (2022).
pubmed: 35082152
pmcid: 8812522
doi: 10.1073/pnas.2117754119
Pramanik, J. et al. Genome-wide analyses reveal the IRE1a-XBP1 pathway promotes T helper cell differentiation by resolving secretory stress and accelerating proliferation. Genome Med. 10, 76 (2018).
Bogdan, D. M. et al. FABP5 deletion in nociceptors augments endocannabinoid signaling and suppresses TRPV1 sensitization and inflammatory pain. Sci. Rep. 12, 9241 (2022).
pubmed: 35655086
pmcid: 9163147
doi: 10.1038/s41598-022-13284-0
Lee, A. H., Scapa, E. F., Cohen, D. E. & Glimcher, L. H. Regulation of hepatic lipogenesis by the transcription factor XBP1. Science 320, 1492–1496 (2008).
pubmed: 18556558
pmcid: 3620093
doi: 10.1126/science.1158042
Iwawaki, T., Akai, R., Yamanaka, S. & Kohno, K. Function of IRE1 alpha in the placenta is essential for placental development and embryonic viability. Proc. Natl Acad. Sci. USA 106, 16657–16662 (2009).
pubmed: 19805353
pmcid: 2757843
doi: 10.1073/pnas.0903775106
Chopra, S. et al. IRE1α–XBP1 signaling in leukocytes controls prostaglandin biosynthesis and pain. Science 365, eaau6499 (2019).
pubmed: 31320508
doi: 10.1126/science.aau6499
de Boer, J. et al. Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur. J. Immunol. 33, 314–325 (2003).
pubmed: 12548562
doi: 10.1002/immu.200310005
Roby, K. F. et al. Development of a syngeneic mouse model for events related to ovarian cancer. Carcinogenesis 21, 585–591 (2000).
pubmed: 10753190
doi: 10.1093/carcin/21.4.585
Ichikawa, T. et al. Chemical fixation creates nanoscale clusters on the cell surface by aggregating membrane proteins. Commun. Biol. 5, 487 (2022).
pubmed: 35595960
pmcid: 9122943
doi: 10.1038/s42003-022-03437-2
Bolte, S. & Cordelieres, F. P. A guided tour into subcellular colocalization analysis in light microscopy. J. Microsc. 224, 213–232 (2006).
pubmed: 17210054
doi: 10.1111/j.1365-2818.2006.01706.x
Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573–3587.e29 (2021).
pubmed: 34062119
pmcid: 8238499
doi: 10.1016/j.cell.2021.04.048
Xu, J. et al. Single-cell RNA sequencing reveals the tissue architecture in human high-grade serous ovarian cancer. Clin. Cancer Res. 28, 3590–3602 (2022).
pubmed: 35675036
pmcid: 9662915
doi: 10.1158/1078-0432.CCR-22-0296
Satija, R., Farrell, J. A., Gennert, D., Schier, A. F. & Regev, A. Spatial reconstruction of single-cell gene expression data. Nat. Biotechnol. 33, 495–502 (2015).
pubmed: 25867923
pmcid: 4430369
doi: 10.1038/nbt.3192
Zheng, L. et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science 374, abe6474 (2021).
pubmed: 34914499
doi: 10.1126/science.abe6474
Andreatta, M. et al. Interpretation of T cell states from single-cell transcriptomics data using reference atlases. Nat. Commun. 12, 2965 (2021).
pubmed: 34017005
pmcid: 8137700
doi: 10.1038/s41467-021-23324-4
Chu, Y. et al. Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance. Nat. Med. 29, 1550–1562 (2023).
pubmed: 37248301
pmcid: 11421770
doi: 10.1038/s41591-023-02371-y
Khan, O. et al. TOX transcriptionally and epigenetically programs CD8
pubmed: 31207603
pmcid: 6713202
doi: 10.1038/s41586-019-1325-x
Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation 2, 100141 (2021).
pubmed: 34557778
pmcid: 8454663